← FDA Drug Approvals (Drugs@FDA)
COMBIVENT RESPIMAT
NDA · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2011-10-07
Drug application
- FDA Application #
NDA021747
- Application type
- New Drug Application
- Brand name
- COMBIVENT RESPIMAT
- Generic name
- IPRATROPIUM BROMIDE AND ALBUTEROL
- Active ingredients
- ALBUTEROL SULFATE; IPRATROPIUM BROMIDE
- Dosage form
- SPRAY, METERED
- Route
- INHALATION
- Marketing status
- Prescription
- Sponsor
- BOEHRINGER INGELHEIM
- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- First approval
- 2011-10-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown